Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists

Authors:

Abstract
Heterocyclic aryl hydrocarbon receptor agonists modulate lymphocyte-mediated tissue repair in a murine model of colitis.
Funding Information
  • National Institutes of Health (T32 HL007734)
  • National Institutes of Health (T35 HL 110843)
  • National Institutes of Health (T35 HL 110843)

This publication has 47 references indexed in Scilit: